Suzhou MedicalSystem Technology Co (SHSE:603990) EBIT : ¥-176.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Suzhou MedicalSystem Technology Co EBIT?

Suzhou MedicalSystem Technology Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was ¥31.2 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-176.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Suzhou MedicalSystem Technology Co's annualized ROC % for the quarter that ended in Mar. 2024 was 2.53%. Suzhou MedicalSystem Technology Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 5.13%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Suzhou MedicalSystem Technology Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -4.54%.

Suzhou MedicalSystem Technology Co EBIT Historical Data

The historical data trend for Suzhou MedicalSystem Technology Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou MedicalSystem Technology Co EBIT Chart

Suzhou MedicalSystem Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

58.55

55.18

58.03

47.53

-213.69

Suzhou MedicalSystem Technology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															-5.73	-36.34	-21.08	-150.54	31.17

Competitive Comparison of Suzhou MedicalSystem Technology Co's EBIT

For the Health Information Services subindustry, Suzhou MedicalSystem Technology Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suzhou MedicalSystem Technology Co's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Suzhou MedicalSystem Technology Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Suzhou MedicalSystem Technology Co's EV-to-EBIT falls into.

Suzhou MedicalSystem Technology Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-176.8 Mil.

Suzhou MedicalSystem Technology Co (SHSE:603990) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Suzhou MedicalSystem Technology Co's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	108.384 * ( 1 - 15.76% )	/	( (3517.243	+	3706.188)	/ 2 )
=	91.3026816	/	3611.7155
=	2.53 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3915.297	-	1030.464	-	( 638.294	-	max(0, 1858.084	-	1225.674	+	638.294	))
=	3517.243

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3991.402	-	879.809	-	( 614.523	-	max(0, 1850.772	-	1256.177	+	614.523	))
=	3706.188

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Suzhou MedicalSystem Technology Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	124.692	/	( ( (2408.318 + max(-764.196, 0))	+	(2451.256 + max(-565.384, 0)) )	/	2 )
=	124.692	/	( ( 2408.318	+	2451.256 )	/	2 )
=	124.692	/	2429.787
=	5.13 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(211.493	+	76.382	+	137.166)	-	(1030.464	+	0	+	158.773)
=	-764.196

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(218.664	+	69.011	+	180.396)	-	(879.809	+	0	+	153.646)
=	-565.384

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Suzhou MedicalSystem Technology Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-176.781	/	3897.167
	=	-4.54 %

Suzhou MedicalSystem Technology Co EBIT Related Terms

Thank you for viewing the detailed overview of Suzhou MedicalSystem Technology Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou MedicalSystem Technology Co (SHSE:603990) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Suzhou MedicalSystem Technology Co Ltd (SHSE:603990) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

222 Guijia Lane, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215021

Website

http://www.medicalsystem.com.cn

Suzhou MedicalSystem Technology Co Ltd develops medical engineering technology and promotes clinical system for operation theatre and intensive care units.

Executives

Wu Di	senior management
Li Biao	Supervisors
Weng Kang	Director
Chen Jian Song	Directors, senior managers
Wang Jian Hua	Director
Fu Hong	Director
Chen Jing	senior management
Kong Feng	Director
Xu Zhi Yuan	senior management
Wu Wang Sheng	senior management
Chen Ze Jiang	Director

Suzhou MedicalSystem Technology Co (SHSE:603990) Headlines

No Headlines